Responding to a Pharmaceutical Fraud Civil Investigative Demand (CID)
So your probably holding this Civil Investigative Demand about pharmaceutical fraud and your entire pharma business is collapsing. Maybe a sales rep promoted off-label uses. Maybe you provided kickbacks disguised as speaker fees. Or maybe your just caught up in there latest crackdown on drug companies. Look, we get it. Your ABSOLUTELY TERRIFIED. And you should be! Because pharmaceutical companies routinely pay HUNDREDS OF MILLIONS and executives face 5 YEARS in federal prison for Anti-Kickback violations!
What Is Pharmaceutical Fraud Under the False Claims Act?
Let me explain the healthcare nightmare your facing. The Anti-Kickback Statute makes ANY payment to induce referrals a federal crime – and DOJ interprets this so broadly that normal pharma marketing becomes criminal!
Did your sales rep mention an off-label use that doctors asked about? FRAUD! Provided educational grants to medical institutions? Kickback! Sponsored a doctor’s conference attendance? CRIMINAL KICKBACK! We’ve seen pharma executives imprisoned for marketing practices every company does!
The False Claims Act turns every prescription influenced by your marketing into a false claim to Medicare/Medicaid. One improper detail to one doctor can trigger liability for THOUSANDS of prescriptions over years! Each prescription is a separate violation carrying up to $27,894 in penalties!
How Devastating Are Pharmaceutical Fraud Penalties?
Sit down before reading because these numbers will destroy your entire company! Recent pharma settlements show the catastrophic scale:
QOL Medical paid $47 MILLION for providing free testing services! Teva Pharmaceuticals paid $450 million for copay assistance programs! Assertio Therapeutics paid $3.6 million just for marketing one fentanyl product! These aren’t outliers – there typical!
But here’s what’s worse – PERSONAL LIABILITY! CEOs face criminal prosecution! Anti-Kickback violations carry 5 years prison and $25,000 fines PER KICKBACK! Had 100 speaker programs? That’s 500 years potential prison time! Obviously nobody gets that, but prosecutors use it to force guilty pleas!
Need Help With Your Case?
Don't face criminal charges alone. Our experienced defense attorneys are ready to fight for your rights and freedom.
- 100% Confidential
- Response Within 1 Hour
- No Obligation Consultation
Or call us directly:
(212) 300-5196What Triggers Pharmaceutical Fraud Investigations?
Your probably wondering “Who turned us in?” Let me tell you what destroys pharma companies:
Whistleblowers are your BIGGEST threat! Qui tam relators get 15-30% of recoveries! That fired sales rep who knows about your marketing practices? They could make $50 million by reporting you! We’ve seen entire sales forces become whistleblowers after layoffs!
Data analytics expose patterns! CMS analyzes prescribing data looking for statistical anomalies. Spike in off-label use after your conference? Red flag! Doctors who attend your programs prescribe more? KICKBACK EVIDENCE! Even legitimate medical education gets twisted into criminal conspiracy!
Todd Spodek
Lead Attorney & Founder
Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.
What About Off-Label Marketing?
Off-label marketing is the DEADLIEST trap in pharma! DOJ aggressively pursues off-label promotion under False Claims Act!
Your pharmaceutical company just received a Civil Investigative Demand from the DOJ requesting five years of sales records, speaker program payments, and internal communications about your top-selling drug. Two former sales reps have already been interviewed, and you suspect the investigation centers on alleged kickbacks to physicians disguised as consulting fees.
How should we respond to this CID without making things worse, and can they use what we produce to build a criminal case against us?
A CID under the False Claims Act (31 U.S.C. § 3733) is a civil tool, but the documents you produce can absolutely be shared with criminal prosecutors through parallel investigation channels. You need to invoke all legitimate objections and privileges immediately — attorney-client privilege, work product doctrine, and any applicable trade secret protections under the protective order provisions of the statute. Your response strategy should include negotiating the scope of production with the issuing attorney, because CIDs are often overbroad and can be narrowed through good-faith discussions before the 20-day deadline. Most critically, do not let employees speak informally with investigators or destroy any documents, as obstruction charges under 18 U.S.C. § 1519 carry up to 20 years and are often easier to prove than the underlying fraud.
This is general information only. Contact us for advice specific to your situation.
FDA approval for one indication doesn’t allow promoting other uses – even if doctors routinely prescribe off-label! Mentioning published studies about off-label use? Illegal promotion! Answering doctor questions about off-label? FRAUD if not done “properly”! We’ve seen companies pay billions for sales reps truthfully discussing medical literature!
The worst part? “Intended use” doctrine means FDA can claim your marketing changed the drug’s intended use, making it “misbranded” and every prescription illegal! Your approved drug becomes unapproved overnight based on sales presentations!
